Skip to main content
MyPeptideMatch
Reviewed by MyPeptideMatch Editorial TeamLast reviewed October 2026Updated October 2026

Vilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide

Vilon (Lys-Glu dipeptide) bioregulator: community-reported dosing, reconstitution math for the 20 mg vial, and what the research does and doesn't support.

Quickstart highlights

Vilon is the synthetic dipeptide Lys-Glu (KE), developed by Vladimir Khavinson's group in St.

  • No human dose has been established. Every amount on this page is community-reported, not from a trial.
  • For the commonly quoted 200 µg: 20 mg vial + 10 mL bac water = 2 mg/mL, so 200 µg = 10 units.
  • At 200 µg per dose, one 20 mg vial holds 100 doses; a 10-day course uses 2 mg.
  • Mouse studies used far smaller amounts, such as 0.1 µg per mouse for five days a month.
  • The research behind Vilon is mostly cell and rodent work. See the Vilon peptide page for the evidence.

Dosing table

For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.

WeekDose (µg)UnitsFrequencyNotes
1-2 (10-day course)20010Once dailyCommunity-reported, not from a trial; 200 µg = 10 units at 2 mg/mL; one 20 mg vial holds 100 doses at this amount
Maintenance20010Every other dayCommunity-reported, not from a trial; no study has tested a maintenance schedule or long-term use in people

Your free Vilon tracker

  • Dose reminders
  • Injection logging
  • Cycle progress
Create free account Already have one? Sign in

Reconstitution steps

  1. Add 10 mL bacteriostatic water to the 20 mg vial (for example in four 2.5 mL portions), running it slowly down the vial wall.
  2. Swirl gently until dissolved; do not shake.
  3. Final concentration: 2 mg/mL. On a U-100 insulin syringe, 200 µg = 10 units.
  4. Label with the date; refrigerate at 2–8 °C and use within 28 days.

Supplies needed

10_day-week plan

  • 1 vial
  • 10 syringes
  • 10 mL bac water
  • 10 alcohol swabs
Need clinics? See vetted providers →

Protocol overview & cycle notes

Reference schedule and reconstitution math for a 20 mg Vilon vial. Vilon has cell and rodent research but only one small human study, so every dose on this page is community-reported, not clinically established.

Off-cycle: Not established. Community sources describe breaks of months between courses; no study has tested cycle length in people.

Storage & handling

Lyophilized: store below 25 °C. Reconstituted: refrigerate 2–8 °C; use within 28 days.

Injection & tracking tips

  • Community protocols describe subcutaneous injection into abdominal or thigh fat; no study has compared routes or timing of day in people.
  • Rotate injection sites and use a new sterile syringe every time.
  • No study has tested this peptide combined with any other peptide, so combination protocols are untested.
  • Vilon is promoted as an immune modulator and has no human safety data. If you have an autoimmune disease, an organ transplant or take immune-suppressing drugs, talk to your physician first.

Tracking

Logging helps you and your provider spot patterns and adjust dose or timing.

  • Record the start date, amount, product lot and certificate of analysis for each course.
  • If your physician orders immune or inflammation labs, get them at baseline and after the course; no study has shown Vilon changes them in people.
  • Note any side effects, including injection-site reactions, and share them with your physician.
Log your cycle in the calculator →

How this works & references

Vilon is the synthetic dipeptide Lys-Glu (KE), developed by Vladimir Khavinson's group in St. Petersburg and described as a thymus-related "bioregulator." In cell studies it increased interleukin-2 gene expression in lymphocytes and loosened condensed chromatin in lymphocytes from elderly donors. In mice it increased physical activity and lowered tumor rates; one study reported a longer lifespan, while a larger paper from the same group reported survival gains only for Epitalon. Human data is limited to one small Russian study in type 1 diabetes, and most of the research comes from Khavinson's network without independent replication.

Frequently asked questions

What is the Vilon peptide dosage?
No human dose has been established. Community-reported schedules for the 20 mg vial are usually 200 µg once daily for 10 days, sometimes followed by every-other-day use. Mouse studies used far smaller amounts, such as 0.1 µg per mouse for five days a month. Treat the online figures as unverified.
What is Vilon peptide used for?
It is marketed for immune support and healthy aging. The research behind that is cell studies on immune cells and chromatin and rodent studies on activity, tumors and lifespan. There is one small Russian human study, in type 1 diabetes, and no placebo-controlled trial.
What are the side effects of Vilon?
There is no human safety data collected in a study. A long-term mouse study reported no unfavorable effects on development, which says little about people. Injected research vials carry risks of site reactions, contamination and uncertain purity.
Can Vilon be taken orally?
Oral products are sold, and one rat study gave Vilon by mouth. Khavinson's group also reports that the KE dipeptide is broken down in solution more readily than some longer bioregulators. How much oral Vilon reaches the blood in people is unknown.
Can Vilon be combined with Epitalon?
People do combine them, but the only study we found that gave both together measured gene expression in mouse heart tissue. No study has tested the combination for lifespan, immunity or any outcome in people.

Related protocols

This content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.